These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21436090)

  • 1. Science to practice: can the diagnosis of fibrosis with magnetization contrast MR aid in the evaluation of patients with Crohn disease?
    Aisen AM
    Radiology; 2011 Apr; 259(1):1-3. PubMed ID: 21436090
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease.
    Adler J; Swanson SD; Schmiedlin-Ren P; Higgins PD; Golembeski CP; Polydorides AD; McKenna BJ; Hussain HK; Verrot TM; Zimmermann EM
    Radiology; 2011 Apr; 259(1):127-35. PubMed ID: 21324841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New magnetic resonance imaging modalities for Crohn disease.
    Yacoub JH; Oto A
    Magn Reson Imaging Clin N Am; 2014 Feb; 22(1):35-50. PubMed ID: 24238131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Contrast-Enhanced Sonography Detect Bowel Wall Fibrosis in Mixed Inflammatory and Fibrotic Crohn Disease Lesions in an Animal Model?
    Dillman JR; Rubin JM; Johnson LA; Moons DS; Higgins PD
    J Ultrasound Med; 2017 Mar; 36(3):523-530. PubMed ID: 28072481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetization transfer for the assessment of bowel fibrosis in patients with Crohn's disease: initial experience.
    Pazahr S; Blume I; Frei P; Chuck N; Nanz D; Rogler G; Patak M; Boss A
    MAGMA; 2013 Jun; 26(3):291-301. PubMed ID: 23138635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of high-resolution MR imaging in demonstrating transmural pathologic changes in Crohn disease.
    Sinha R; Rajiah P; Murphy P; Hawker P; Sanders S
    Radiographics; 2009 Oct; 29(6):1847-67. PubMed ID: 19959525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of MRI enhancement kinetics for evaluation of inflammatory activity in Crohn's disease.
    Röttgen R; Grandke T; Grieser C; Lehmkuhl L; Hamm B; Lüdemann L
    Clin Imaging; 2010; 34(1):29-35. PubMed ID: 20122516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls.
    Sinha R; Verma R; Verma S; Rajesh A
    AJR Am J Roentgenol; 2011 Jul; 197(1):76-9. PubMed ID: 21701013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR enterography of Crohn disease: part 2, imaging and pathologic findings.
    Sinha R; Verma R; Verma S; Rajesh A
    AJR Am J Roentgenol; 2011 Jul; 197(1):80-5. PubMed ID: 21701014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR enterography in the management of patients with Crohn disease.
    Leyendecker JR; Bloomfeld RS; DiSantis DJ; Waters GS; Mott R; Bechtold RE
    Radiographics; 2009 Oct; 29(6):1827-46. PubMed ID: 19959524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of the small bowel in Crohn disease.
    Al-Hawary MM; Zimmermann EM; Hussain HK
    Magn Reson Imaging Clin N Am; 2014 Feb; 22(1):13-22. PubMed ID: 24238129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized density-weighted imaging for dynamic contrast-enhanced 3D-MR mammography.
    Gutberlet M; Roth A; Hahn D; Köstler H
    J Magn Reson Imaging; 2011 Feb; 33(2):328-39. PubMed ID: 21274974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the distribution of magnetic nanoparticles with ultrasound.
    Norton SJ; Vo-Dinh T
    IEEE Trans Med Imaging; 2007 May; 26(5):660-5. PubMed ID: 17518060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the image quality of contrast-enhanced MR angiography by automated image registration: a prospective study in peripheral arterial disease of the lower extremities.
    Menke J
    Eur J Radiol; 2010 Sep; 75(3):e1-8. PubMed ID: 19656648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encoding to the longitudinal magnetization for MR imaging and flow velocity mapping.
    Hsu JJ; Lowe IJ
    J Magn Reson; 2006 Nov; 183(1):41-9. PubMed ID: 16904356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of liver T₁ and T₂ relaxation times in an experimental mouse model of liver fibrosis.
    Chow AM; Gao DS; Fan SJ; Qiao Z; Lee FY; Yang J; Man K; Wu EX
    J Magn Reson Imaging; 2012 Jul; 36(1):152-8. PubMed ID: 22334510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast behavior of high-spatial-resolution T1-weighted MR imaging at 3.0 T vs. 1.5 T.
    Isoda H; Arizono S; Shimada K; Hirokawa Y; Maetani YS; Kataoka M; Nakamoto Y; Shibata T; Togashi K
    Clin Imaging; 2011; 35(2):133-8. PubMed ID: 21377052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity.
    Horsthuis K; Lavini C; Bipat S; Stokkers PC; Stoker J
    Radiology; 2009 May; 251(2):380-7. PubMed ID: 19401571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate T(1) quantification using a magnetization-prepared spiral technique.
    Foltz WD; Haider MA; Chung P; Bayley A; Catton C; Ramanan V; Jaffray D; Wright GA; Ménard C
    J Magn Reson Imaging; 2011 Feb; 33(2):474-81. PubMed ID: 21274991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.